Details

Last Funding Type

Series B

Last Funding Money Raised

$60M

Industries

Biopharma,Biotechnology,Life Science

Founded date

Jan 1, 2017

Number Of Employee

1 - 10

Operating Status

Active

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.